Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Sheraton Philadelphia Downtown Hotel

Oct 24, 2024 7:30 AM - Oct 25, 2024 4:10 PM

201 North 17th Street, Philadelphia, PA 19103

Real-World Evidence Conference

Translating Insights into Real-World Value

Session 9: Is the Future Here, Near, or Neither? Exploring the Intersection of AI and RWD in Pharmacoepidemiology

Session Chair(s)

Keri  Monda, PhD, MS

Keri Monda, PhD, MS

Executive Director, Center for Observational Research

Amgen, United States

This session will highlight current innovative explorations when applying artificial intelligence to RWD sources. The first presentation will share lessons learned and opportunities for extracting and incorporating data from unstructured EHR clinical notes using NLP into structured data to improve the validity of pharmacoepidemiology studies. The second presentation will discuss principles and present case studies around using generative AI to transform the design of clinical studies. The third presentation delves into the details of using ML to optimize patient selection for clinical trials as viewed from a personalized medicine lens. We will wrap up with an exploration of numerous policy principles that can inform the development of effective policy and regulatory frameworks on the intersection of RWD and AI.

Learning Objective :
  • Demonstrate the benefits and challenges of using information extracted from clinical notes using NLP in a pharmacoepidemiology study
  • Better understand the role of generative AI in optimizing clinical study designs
  • Evaluate the potential of ML to enable predictive treatment effect modeling from real-world data
  • Contemplate the implications of generative AI from a policy perspective

Speaker(s)

Jenna  Wong, PhD, MSc

Natural Language Processing in Pharmacoepidemiology: Lessons from the Multi-source Observational Safety study for Advanced Information Classification using NLP (MOSAIC-NLP)

Jenna Wong, PhD, MSc

Harvard Medical School and Harvard Pilgrim Health Care Institute, United States

Assistant Professor, Department of Population Medicine

Susant  Mallick, MBA

Unleashing RWD and RWE: Transforming Clinical Study Design with Generative AI

Susant Mallick, MBA

Cloudhub BV, Netherlands

Founder and CEO, Life Sciences Practice Leader

Flavio  Dormont, PhD, MBA, MS

Leveraging RWD to Enable Predictive Treatment Effect Modelling in Personalized Medicine

Flavio Dormont, PhD, MBA, MS

Sanofi, United States

Therapeutic Area Head, Clinical Development RWE

Emilie  Scherrer, MS

The Role of Real-World Data in AI Policy

Emilie Scherrer, MS

Tempus AI, United States

Head of Health Economics & Outcomes Research

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.